I recently interview Arnold Caplan, the father of the MSC field, and published part 1 of the interview (you can read it here). Today in part 2 we cover more topics of great importance related to MSCs including propagation, placebos, and patients as well as publishing. A hot topic in the stem cell world more …
A few days ago I had a long, very enjoyable phone conversation with the father of the mesenchymal stem cells (MSC) field, Dr. Arnold Caplan. Dr. Caplan is Professor of Biology, Director Skeletal Research Center at Case Western. He coined the phrase “mesenchymal stem cell” in the late 1980s. I’m going to break the interview …
Insightful interview with Arnold Caplan: Part 1: MSC history, nomenclature, & properties Read More »
Businessweek just published a very long, interesting article on Celltex by Susan Berfield yesterday. I was happy to talk with Susan at length about the key issues and be quoted in the article. See image at left of two key Celltex leaders, David Eller, CEO of Celltex, and Stan Jones above (Photograph by Thomas Prior …
Nuggets and pyrite in Businessweek article on Celltex Read More »
The strange, doubt-filled story that iPS cells have already been transplanted into human patients is generating a great deal of interest today even as Harvard officially indicates it never approved any such work. According to the original Japanese newspaper report, Dr. Hisashi Moriguchi transplanted iPS cell-derived heart cells into patients, work approved by Harvard. The …
Autism affects millions of children in the U.S. alone; could stem cells for autism help? It is a perplexing spectrum of disorders with “autism” being an umbrella term for a host of related neurological illnesses. The negative impact of autism on our society transcends economics, but has been estimated at 10s of billions of dollars. …